Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia

Lorenzo Ball, Marcus J. Schultz, Paolo Pelosi

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English
Journal	The Lancet Respiratory Medicine
DOIs	https://doi.org/10.1016/S2213-2600(20)30513-0
Publication status	Accepted/In press - 2021

ASJC Scopus subject areas

@article{0d0bc511424b4f1c9a5230090fc47844,

title = "Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia",

author = "Lorenzo Ball and Schultz, {Marcus J.} and Paolo Pelosi",

year = "2021",

doi = "10.1016/S2213-2600(20)30513-0",

language = "English",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Nebulised heparin for patients on ventilation

T2 - implications for COVID-19 pneumonia

AU - Ball, Lorenzo

AU - Schultz, Marcus J.

AU - Pelosi, Paolo

PY - 2021

Y1 - 2021

UR - http://www.scopus.com/inward/record.url?scp=85100690597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85100690597&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(20)30513-0

DO - 10.1016/S2213-2600(20)30513-0

M3 - Comment/debate

C2 - 33493452

AN - SCOPUS:85100690597

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

SN - 2213-2600

ER -